Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study
ConditionNail Psoriasis
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorHexsel Dermatology Clinic
About this trial
To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.
Eligibility criteria
Qualifiers
Presence of nail psoriasis in at least one fingernail or toenail;
Patients not using systemic medication, or without adequate response to systemic medication after at least 6 months of use;
Ability to read, understand, and sign the Informed Consent Form (ICF) and the Consent Form for Images, Presentations, and Scientific Publications.
Disqualifiers
History of sensitivity to any components of the study product;
Initiation of systemic medication for nail psoriasis less than six months prior.
Trial design
Treatments tested in this trial
- Topical 2% Tofacitinib
Treatment groups
10 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov